Search research articles
Contact Us
Filters
Showing results (11-20 of 413) with videos related to
Page
of 42
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)
|
November 4, 2021
Ischemic Penumbra: A Personal View
Stephen M Davis, Geoffrey A Donnan
Stroke
|
August 1, 2009
Angiotensin receptor blockers and stroke therapy: it is all about the blood pressure
Geoffrey A Donnan, Stephen M Davis
Stroke
|
March 17, 2009
The ethics of thrombolytic trials beyond 3 (or 4.5) hours: randomized controlled trials are required to change clinical practice
Geoffrey A Donnan, Stephen M Davis
Stroke
|
September 13, 2003
Ischemic penumbra: MRI or PET
Stephen M Davis, Geoffrey A Donnan
Stroke
|
January 10, 2002
Neuroprotection: establishing proof of concept in human stroke
Stephen M Davis, Geoffrey A Donnan
Stroke
|
January 4, 2003
Heparin in stroke: not for most, but the controversy lingers
Geoffrey A Donnan, Stephen M Davis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2002
Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels
Emma J Lang, Stephen M Davis
Stroke
|
March 18, 2006
The stroke-prone state: rapid assessment of transient ischemic attacks
Stephen M Davis, Geoffrey A Donnan
Practical Neurology
|
June 22, 2024
Stroke is not optional for neurologists
Matthew C Kiernan, Stephen M Davis
Stroke
|
March 8, 2008
Thunderclap headache: CT and lumbar puncture but occasionally more!
Stephen M Davis, Geoffrey A Donnan
Page
of 42
Search research articles
Search
Showing results (11-20 of 413) with videos related to
Sort By:
Page
of 42
Cerebrovascular Diseases (Basel, Switzerland)
|
November 4, 2021
Ischemic Penumbra: A Personal View
Stephen M Davis, Geoffrey A Donnan
Stroke
|
August 1, 2009
Angiotensin receptor blockers and stroke therapy: it is all about the blood pressure
Geoffrey A Donnan, Stephen M Davis
Stroke
|
March 17, 2009
The ethics of thrombolytic trials beyond 3 (or 4.5) hours: randomized controlled trials are required to change clinical practice
Geoffrey A Donnan, Stephen M Davis
Stroke
|
September 13, 2003
Ischemic penumbra: MRI or PET
Stephen M Davis, Geoffrey A Donnan
Stroke
|
January 10, 2002
Neuroprotection: establishing proof of concept in human stroke
Stephen M Davis, Geoffrey A Donnan
Stroke
|
January 4, 2003
Heparin in stroke: not for most, but the controversy lingers
Geoffrey A Donnan, Stephen M Davis
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 3, 2002
Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels
Emma J Lang, Stephen M Davis
Stroke
|
March 18, 2006
The stroke-prone state: rapid assessment of transient ischemic attacks
Stephen M Davis, Geoffrey A Donnan
Practical Neurology
|
June 22, 2024
Stroke is not optional for neurologists
Matthew C Kiernan, Stephen M Davis
Stroke
|
March 8, 2008
Thunderclap headache: CT and lumbar puncture but occasionally more!
Stephen M Davis, Geoffrey A Donnan
Page
of 42